melengestrol acetate has been researched along with Prostatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Battistone, MJ; Padilla, GM; Petrow, V | 1 |
| Padilla, GM; Padilla, JJ; Payne, B; Petrow, V; Yacullo, RC | 1 |
2 other study(ies) available for melengestrol acetate and Prostatic Neoplasms
| Article | Year |
|---|---|
1-dehydro-melengestrol acetate inhibits the growth and protein kinase C activity of androgen-independent Dunning rat prostatic tumors.
Topics: Androgens; Animals; Antineoplastic Agents; Cell Division; Cytosol; Male; Melengestrol Acetate; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Protein Kinase C; Rats; Rats, Inbred Strains | 1993 |
Melengestrol acetate and megestrol acetate are prostatic tumor inhibiting agents.
Topics: Adrenal Glands; Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Male; Megestrol; Megestrol Acetate; Melengestrol Acetate; Neoplasms, Hormone-Dependent; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Seminal Vesicles | 1990 |